Health Trials

ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)

ConditionCoronary Artery Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorEmory University

About this trial

The primary objective of this protocol is to develop a comprehensive, multicenter international prospective registry to capture long-term clinical outcomes for adult patients undergoing percutaneous coronary intervention (PCI) with drug-coated balloons (DCB) for de novo coronary artery disease.

Eligibility criteria

Qualifiers

All adult patients (≥ 18 years of age) undergoing PCI for de novo CAD using DCB

Disqualifiers

Patients under the age of 18; PCI procedures without the utilization of DCB; PCI procedures for non de novo lesions

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

5,000 Participants
are grouped into 1 trial group

Sponsors and collaborators

Emory University

Lead sponsor

Source ClinicalTrials.gov